RANEXA 500 MG

Valsts: Izraēla

Valoda: angļu

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

RANOLAZINE 500 MG

Pieejams no:

NEOPHARM LTD

ATĶ kods:

C01EB18

Zāļu forma:

TABLETS EXTENDED RELEASE

Ievadīšanas:

PER OS

Ražojis:

CV THERAPEUTICS INC, USA

Ārstniecības grupa:

RANOLAZINE

Ārstēšanas norādes:

Ranexa is indicated for the treatment of chronic angina. Ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).Ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.

Autorizācija datums:

2010-10-01